Table 1
(continued)
Main focus
Type of CW
a,
b
Compounds reported
b
Number of
publications
revised
Removal Kinetics
Removal
mechanisms
Design and/or
operation
considerations Reference
Chiral pharmaceuticals
Ns
Ns
16
No
No
Yes (brief
mention)
No
[58]
Lemna minor and
phytoremediation
Ns
Caffeine, cefadroxil, cisplatin, diclofenac,
fluoxetine,
ibuprofen, metronidazole,
naproxen, sulfamethoxazole,
trimethoprim, others ns
10
Yes
No
No
No
[54]
Adsorbents and
non-steroidal anti-inflammatory drugs
Ns
Diclofenac, ibuprofen,
naproxen
5
Yes
No
No
No
[53]
Phytoremediation % plantmicrobe interaction
SF, HSSF,
VF and
others ns
Most common: caffeine, carbamazepine, diclofenac, ibuprofen, ketoprofen,
naproxen, others ns
80 (not only
about CWs)
Yes
No
Yes (mostly
focused on
microbial
degradation)
Yes
[60]
CWs + algae and
pharmaceuticals
SF, HSSF,
VF and
others ns
39 compounds. Most common: caffeine, carbamazepine, diclofenac, ibuprofen,
ketoprofen and naproxen
21
Yes
No
Yes (brief
mention)
No
[59]
Antibiotics + antibioticresistant genes and CWs
SF, HSSF,
VF, hybrid
and others
Sulfonamide antibiotics,
quinolone antibiotics, tetracycline antibiotics,
macrolactone antibiotics,
chloramphenicol antibiotics,
polyether antibiotics and
beta-lactam antibiotics
39
Yes
No
Yes
No
[61]
386
P. N. Carvalho
Précédent

- 389/529

Suivant